Mediators of Inflammation · 2009 · 13 citations · 27 references
Life SciencesCardiologyGeneticsGenetic EpidemiologyHuman GeneticsMedical GeneticsCardiac BiomarkersCardiovascular DiseaseGenetic RiskIschemic Heart DiseaseAtherosclerosis GeneticsCardiovascular Genetic RiskControl Group DesignMatched Control GroupMyocardial Ischemia MarkersSingle-nucleotide Polymorphism AnalysisSingle-nucleotide Polymorphism VariationSubjects
The aim of our work was to find if MCP-1 -2518 (A/G) single nucleotide polymorphism (SNP) influences somehow the serum concentrations of high-sensitive CRP (hsCRP) both in patients suffering from ischemic heart disease (IHD), myocardial infarction (MI), angina pectoris (AP), and hypertension (HT) and in control group of healthy subjects. Totally, 263 patients with the diagnosis of IHD, out of them 89 with MI, 145 with AP, 205 with HT, and also 67 healthy subjects were included in the study. First, we estimated the serum levels of hsCRP. We found that patients with AP had significantly higher serum level of hsCRP than both control group of healthy subjects (P = .043) and IHD patients without AP (P = .026). The presence of the mutant G allele statistically significantly correlated with the higher serum levels of hsCRP in patients with IHD (P = .016), AP (P = .004), and HT (P = .013). Higher correlations were found in men (AP: P = .019; HT: P = .047). In all cases the highest levels of hsCRP were found both in patients and healthy controls with homozygous GG genotype.
27
C-reactive protein: a critical update
Mark B. Pepys, Gideon M. Hirschfield · Journal of Clinical Investigation · 2003 · 3.4K citations · Full text
Cardiovascular Survey Methods.
Geoffrey Rose, H Blackburn · Annals of Internal Medicine · 1968 · 3.1K citations